In the Blood Reagents price fixing case, Faruqi & Faruqi represents a proposed class of direct purchasers of blood reagent products, challenging conspiracy to fix prices, in violation of § 1 of the Sherman Act. Plaintiffs have alleged that defendants Immucor and Ortho-Clinics Diagnostics, a subsidiary of Johnson & Johnson, consolidated the market for blood reagents in the early 2000s in order to raise the price to supracompetitive levels. As a result of this alleged conspiracy, plaintiffs paid far more for blood reagents than they would have in a competitive market. Plaintiffs have settled with Ortho-Clinics Diagnostics and are in the process of seeking Court approval of the settlement in 2012.
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.
Filed on 06/02/2009
1617 JFK Boulevard, Suite 1550
19103 Philadelphia, Pennsylvania
Phone (215) 277-5770
Fax (215) 277-5771
Peter Kohn firstname.lastname@example.org Phone (215) 277-5770 Fax (215) 277-5771